RYTHM Q2 Revenue Surges to $23M on Fixed Licensing Deal; $80M Debt Maturity Looms
RYM sits 47% above its 52-week low of $14 on elevated volume (1.9× avg).
Summary
RYTHM posted Q2 revenue of $23 million and net income of $1.2 million, but faces $80 million in debt maturities and a looming federal ban on its hemp-derived THC products.
Key Events · Earnings and Guidance · RYM
-
Q2 Revenue Hits $23M
Revenue surged 73% sequentially to $23.0 million, driven by $17.5 million in licensing fees from a fixed annual agreement with Green Thumb and $5.5 million in product sales.
-
Net Income Turns Positive
Net income was $1.2 million, or $0.09 per share, compared to a $7.4 million loss a year ago, boosted by a $1.2 million tax benefit from releasing valuation allowances.
-
$80M Debt Maturity Looms
Convertible notes totaling $80 million mature by February 2027, with $72 million held by related party Green Thumb. Management expects to extend or convert the notes, but cash repayment would strain liquidity.
-
Federal Ban Threatens Core Products
Legislation effective November 12, 2026 would cap THC content at 0.4 mg per container, potentially forcing reformulation or discontinuation of RYTHM's hemp-derived beverages and edibles.
Analysis · RYM · Industrial Applications And Services
A new $70 million annual fixed licensing agreement with Green Thumb propelled RYTHM's Q2 revenue to $23 million, swinging the bottom line to a net profit of $1.2 million. The turnaround was further aided by a $26.8 million non-cash tax benefit from releasing its valuation allowance. Yet significant challenges remain: $80 million in convertible notes mature by February 2027, with $72 million held by a related party, creating refinancing risk. Adding to the pressure, a pending federal ban on hemp-derived THC products effective November 2026 threatens the core product line, and a shareholder vote on August 10 could unlock massive dilution if Green Thumb converts its notes and warrants.
How filings like this one have moved
In the 30 days to Oct 18, 2026, 37.5% of the 944 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.75%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RYM was trading at $20.65 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $45M. The 52-week trading range was $14.00 to $53.65. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.